Free T4 (Thyroxine)

MCH (Mean Corpuscular Hemoglobin)

Apolipoprotein B

Sed Rate (Erythrocyte Sedimentation Rate)

VLDL Cholesterol (calculated)

Platelet Count

Neutrophils (Absolute)

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance)

Chloride

Serum Iron

BUN/Creatinine Ratio

eGFR (Estimated Glomerular Filtration Rate)

Ceruloplasmin

DHA (Docosahexaenoic Acid)

25(OH)D (25-Hydroxyvitamin D)

Alkaline Phosphatase (ALP)

Free T3 (Triiodothyronine)

Triglycerides

Free Testosterone

Lymphocytes (Absolute)

Cystatin C

Phosphorous

Lactic Acid

ALT (Alanine Aminotransferase)

TPO Ab (Thyroid Peroxidase Antibodies)

ApoA/ApoB Ratio

Serum Cortisol

Uric Acid

Hematocrit

GGT (Gamma-Glutamyl Transferase)

TIBC (Total Iron Binding Capacity)

HDL Cholesterol

Immature Granulocytes

Insulin

RDW (Red Cell Distribution Width)

WBC (White Blood Cell Count)

Bilirubin (Total and Direct)

AST (Aspartate Aminotransferase)

HS-CRP (High-Sensitivity C-Reactive Protein)

Hemoglobin A1C

ALP is a biomarker commonly used for assessing longevity. Maintaining optimal levels of this enzyme can be a key indicator of overall health and longevity.

Alkaline Phosphatase (ALP)

Alkaline Phosphatase (ALP) is a biomarker that is often used in longevity studies to assess overall health and potential lifespan. ALP levels in the blood can indicate liver or bone health, as well as other metabolic processes. High ALP levels may suggest underlying liver disease or bone disorders, while low levels can be associated with malnutrition or certain genetic conditions. Monitoring ALP as part of a comprehensive biomarker panel can provide valuable insights into an individual’s overall health and potential longevity, helping to identify areas for intervention and personalized health optimization strategies.

Biomarker Explained

Alkaline Phosphatase (ALP) is a crucial biomarker utilized in longevity studies to evaluate an individual’s overall health and potential lifespan. ALP levels in the blood can yield valuable information regarding liver and bone health, as well as other metabolic processes. Elevated ALP levels may indicate underlying liver disease or bone disorders, necessitating further investigation and potential intervention. On the other hand, low ALP levels can be associated with malnutrition or certain genetic conditions, highlighting the need for personalized health optimization strategies. Monitoring ALP as part of a comprehensive biomarker panel can offer insightful data on an individual’s overall health and potential longevity, enabling the identification of areas for intervention and the development of personalized health strategies. This underscores the importance of incorporating ALP into longevity studies and personalized health plans to maximize overall well-being and longevity potential.

Keywords:

Alkaline Phosphatase, ALP, Biomarker, Longevity, Liver health, Bone health, Personalized health strategies

Complete Patient Intake Form

Continue Browsing Our Offers